GMAB Genmab

Watchlist

19.760
-0.080-0.40%

Close Mar 21 16:00 ET

19.850
+0.090+0.46%

Post 20:01 ET

12.56BMarket Cap11.19P/E (TTM)

About Genmab Company

Genmab A/S is an international biotechnology company, which engages in the development of human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline includes daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma, teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease, and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia. The company was founded by Donald Lee Drakeman, Florian Schonharting, and Jan G. J. van de Winkel on June 11, 1998, and is headquartered in Copenhagen, Denmark.

Company Profile

SymbolGMAB

Company NameGenmab

Listing DateJul 18, 2019

Issue Price17.75

Founded1998

CEODr. Jan G. J. van de Winkel, PhD

MarketNASDAQ

Employees2682

Securities TypeDR

ADS Ratio10.0 : 1.0

Fiscal Year Ends12-31

AddressCarl Jacobsens Vej 30,Valby

CityCopenhagen

ProvinceCentral Denmark

CountryDenmark

Zip Code2500

Phone45-70-20-27-28

Websitehttp://www.genmab.com

Company Executives

Name
Position
Salary

Dr. Jan G. J. van de Winkel, PhD
President and Chief Executive Officer
54.80M

Dr. Judith Klimovsky, M.D.
Executive Vice President and Chief Development Officer
27.90M

Dr. Tahamtan Ahmadi, PhD
Executive Vice President, Chief Medical Officer and Head of Experimental Medicines
25.80M

Birgitte Stephensen
Executive Vice President and Chief Legal Officer
13.20M

Rayne Waller
Executive Vice President and Chief Technical Operations Officer
7.30M

Christopher Cozic
Executive Vice President and Chief People Officer
16.60M

Brad Bailey
Executive Vice President and Chief Commercial Officer
11.10M

Anthony Pagano
Executive Vice President and Chief Financial Officer
24.00M

Dr. Martine J. van Vugt, PhD
Executive Vice President and Chief Strategy Officer
11.00M

Dr. Mijke Zachariasse
Director, Vice President and Head of Antibody Research Materials
1.60M

Deirdre P. Connelly
Chairman of the Board
3.30M

Pernille Erenbjerg
Deputy Chairman of the Board
2.60M

Martin Schultz
Director, Senior Director and Head of Development Business Partnership and Strategy
1.40M

Takahiro Hamatani
Director and Senior Director, Finance Japan
1.40M

Anders Gersel Pedersen, M.D.,PhD
Director
2.10M

Dr. Paolo Paoletti, M.D.
Independent Director
1.90M

Elizabeth G. O’Farrell
Independent Director
2.60M

Rolf Karl-Heinz Hoffmann
Independent Director
2.00M

GMAB Genmab

About Genmab Company

Company Profile

Company Executives

Market Insights